    <SEC-DOCUMENT>0001601830-24-000043-index.html : 20240423
    <SEC-HEADER>0001601830-24-000043.hdr.sgml : 20240423
    <ACCEPTANCE-DATETIME>20240423172951
    ACCESSION NUMBER:		0001601830-24-000043
    CONFORMED SUBMISSION TYPE:	ARS
    PUBLIC DOCUMENT COUNT:		1
    CONFORMED PERIOD OF REPORT:	20231231
    FILED AS OF DATE:		20240423
    DATE AS OF CHANGE:		20240423
    EFFECTIVENESS DATE:		20240423

    FILER:

    	COMPANY DATA:
    		COMPANY CONFORMED NAME:			RECURSION PHARMACEUTICALS, INC.
    		CENTRAL INDEX KEY:			0001601830
    		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
    		ORGANIZATION NAME:           	03 Life Sciences
    		IRS NUMBER:				464099738
    		STATE OF INCORPORATION:			DE
    		FISCAL YEAR END:			1231

    	FILING VALUES:
    		FORM TYPE:		ARS
    		SEC ACT:		1934 Act
    		SEC FILE NUMBER:	001-40323
    		FILM NUMBER:		24866078

    	BUSINESS ADDRESS:
    		STREET 1:		41S RIO GRANDE STREET
    		CITY:			SALT LAKE CITY
    		STATE:			UT
    		ZIP:			84101
    		BUSINESS PHONE:		(385) 269-0203

    	MAIL ADDRESS:
    		STREET 1:		41S RIO GRANDE STREET
    		CITY:			SALT LAKE CITY
    		STATE:			UT
    		ZIP:			84101

    	FORMER COMPANY:
    		FORMER CONFORMED NAME:	Recursion Pharmaceuticals, LLC
    		DATE OF NAME CHANGE:	20140305
    </SEC-HEADER>
    <DOCUMENT>
    <TYPE>ARS
    <SEQUENCE>1
    <FILENAME>rxrxannualreport.pdf
    <DESCRIPTION>ARS
    <TEXT>
    Document 1 - file: rxrxannualreport.pdf

    </DOCUMENT>
    </SEC-DOCUMENT>